BOSTON--(BUSINESS WIRE)--The Institute for Protein Innovation (IPI), a nonprofit probe enactment advancing macromolecule subject to accelerate biomedical probe and amended quality health, contiguous announced the assignment of Kenneth Fasman, Ph.D., arsenic President and Chief Executive Officer. Dr. Fasman comes to IPI from The Jackson Laboratory (JAX), wherever helium served arsenic Senior Vice President for Research.
IPI’s Board recognized that Dr. Fasman’s unsocial acquisition successful the academic, concern and nonprofit sectors would facilitate the Institute successful fulfilling its ngo and ambition. IPI aims to supply protein-based probe resources and tools, beforehand macromolecule subject done investigator-driven probe and augment the acquisition of beingness scientists. Specifically, Dr. Fasman volition pb IPI in:
- Scaling IPI's synthetic recombinant antibody level to wide service technological communities done collaboration and antibody distribution.
- Implementing a sustainable exemplary of autarkic probe conducted by IPI module and fellows that enhances the level and applies macromolecule tools and methods to recognize quality biology and illness much deeply.
- Developing an acquisition programme to beforehand and disseminate the starring borderline of macromolecule science.
"There aren't galore institutions aiming to beryllium some a world-class world probe enactment and a sustainable nonprofit supplier of resources, tools and services for the beingness subject community," Dr. Fasman said. "I tin bring my acquisition enhancing the originative concern betwixt these 2 components. Our extremity is to person the aforesaid interaction connected macromolecule subject that institutions similar the Broad oregon Sanger Institutes did for genomics."
A person successful collaborative technological probe and absorption of exertion platforms for biomedical research, Dr. Fasman directed R&D Informatics and Drug Development Strategy and Performance astatine AstraZeneca and served arsenic Chief Scientific Officer astatine the Adelson Medical Research Foundation anterior to joining JAX successful 2015. Dr. Fasman holds a Ph.D. successful biomedical engineering from the Johns Hopkins University School of Medicine and a B.S.E successful electrical engineering and machine subject from Princeton University.
His accomplishment astatine IPI comes astatine a fortuitous clip of maturation for the organization. The Institute was founded successful 2017 by Harvard Medical School professors Timothy Springer, Ph.D., and Andrew Kruse, Ph.D., and launched by Dr. Springer’s philanthropy.
“Over the past 2 years, IPI has optimized its exertion and much intelligibly targeted its antibody level to service technological communities successful fields similar neuroscience, wherever accepted antibodies are lacking,” said Rob Meijers, Ph.D., Interim Executive Director of IPI and Director of the Antibody Platform. “On behalf of IPI and its Board, I invited Ken to instrumentality america into the adjacent chapter, expanding our module and mounting america up for organisation of our antibodies."
IPI Strengthens Board of Directors
To further steer IPI toward improvement and expansion, IPI named Samantha Singer, M.B.A., arsenic Chair of the Board of Directors and elected Stephen Blacklow, M.D., Ph.D., arsenic a caller subordinate of the Board.
Ms. Singer is an experienced biotechnology person with much than 2 decades of institution creation, firm improvement and operations expertise. She presently serves arsenic President and Chief Executive Officer of Abata Therapeutics and is simply a erstwhile subordinate of the Board of Directors of the 5:01 Special Acquisition Corp. Previously, Ms. Singer was an entrepreneur-in-residence astatine Third Rock Ventures, specializing successful institution instauration crossed the firm's portfolio. Her past roles see Chief Operating Officer of the Broad Institute and Vice President for Corporate Strategy and Chief of Staff astatine Biogen Inc. Ms. Singer holds an M.S. successful molecular biology from The Rockefeller University and an M.B.A from Harvard Business School.
"The astir important factors successful gathering a biotech, whether nonprofit oregon for-profit, are having a compelling mission, getting large radical down it and creating an situation wherever they tin thrive and present connected the vision," Ms. Singer says. "IPI has that mission. It has Tim Springer's vision. Now it has Ken's endowment and acquisition arsenic a top-notch executive. I'm excited to beryllium portion of this team."
Dr. Blacklow is the Gustavus Adolphus Pfeiffer Professor and Chair of the Department of Biological Chemistry and Molecular Pharmacology astatine Harvard Medical School and is simply a subordinate of the Department of Cancer Biology astatine the Dana Farber Cancer Institute. Dr. Blacklow is simply a recipient of the National Cancer Institute's prestigious Outstanding Investigator Award and was elected to the Association of American Physicians successful 2018. Dr. Blacklow holds an M.D. and a Ph.D. successful bioorganic chemistry from Harvard University, completed his residency successful objective pathology astatine Brigham and Women's Hospital, and carried retired postdoctoral probe astatine the Whitehead Institute for Biomedical Research.
"I judge successful the intent of IPI and its mission," Dr. Blacklow says. “Going good beyond providing an antibody repertoire to the technological community, IPI is poised to beryllium uniquely innovative and originative successful the macromolecule subject space."
Save the Date
To people its advancement and stock its imaginativeness for the adjacent signifier of development, IPI is pleased to denote it volition beryllium hosting its archetypal symposium. The event, entitled "IPI Surfacing," volition beryllium an in-person technological gathering with talks and discussions from starring scientists worldwide, including Christopher Garcia, Ph.D., from Stanford University, Yvonne Jones, Ph.D., from the University of Oxford, Andreas Plückthun, Ph.D., from the University of Zurich and Junichi Takagi, Ph.D., from Osaka University. The symposium volition beryllium held astatine the Joseph B. Martin Conference Center, Harvard Medical School, Boston, Massachusetts, connected June 15, 2023. Additional lawsuit details volition beryllium shared successful the coming months.
About IPI
The Institute for Protein Innovation (IPI) is pioneering a caller attack to technological find and collaboration. As a nonprofit probe institute, we supply academia and manufacture with synthetic antibodies and heavy macromolecule expertise, empowering researchers to unlock the astir elusive mysteries of biology. Our ngo is to beforehand macromolecule subject to accelerate probe and amended quality health.
English (US)